DaVita Inc. (DVA) is a publicly traded Healthcare sector company. As of July 14, 2026, DVA trades at $235.28 with a market cap of $14.94B and a P/E ratio of 21.53. DVA moved -0.25% today. Year to date, DVA is +106.98%; over the trailing twelve months it is +65.26%. Its 52-week range spans $101.00 to $239.64. Analyst consensus is buy with an average price target of $222.80. Rallies surfaces DVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for DVA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $235.28 |
| Market Cap | $14.94B |
| P/E Ratio | 21.53 |
| EPS | $10.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $239.64 |
| 52-Week Low | $101.00 |
| Volume | 40.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $13.84B |
| Net Income | $1.12B |
| Gross Margin | 0.00% |
5 analysts cover DVA: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $222.80.